ClinConnect ClinConnect Logo
Search / Trial NCT05627674

Precision Prevention Strategy to Increase Uptake and Engagement in Lung Cancer Screening and Smoking Cessation Treatment

Launched by WASHINGTON UNIVERSITY SCHOOL OF MEDICINE · Nov 15, 2022

Trial Information

Current as of July 23, 2025

Enrolling by invitation

Keywords

Precision Prevention Genetically Informed Interventions Lung Cancer Screening Tobacco Treatment Risk Feedback

ClinConnect Summary

The overarching goal of this study is to test the impact of a precision risk feedback tool aiming to address gaps in clinician and patient uptake of lung cancer screening and tobacco treatment. This study builds on evidence that (1) clinical and genetic factors may inform precision risk on lung cancer and smoking cessation and (2) increasingly high demand for personal genetic risk in particular may signal its potential to activate behavior change. The multi-level precision prevention intervention to be tested--RiskProfile-- provides the opportunity to present personalized clinical and genet...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • CLINICIANS:
  • - Primary care clinician with active caseload in participating clinics
  • PATIENTS:
  • Patient of participating primary care clinician
  • Lung cancer screening naïve
  • Between 50 to 80 years of age, inclusive
  • Current or former smokers
  • Pack years ≥ 20
  • English-speaking
  • Exclusion Criteria:
  • PATIENTS:
  • Lung cancer diagnosis
  • Current order placed for lung cancer screening

About Washington University School Of Medicine

Washington University School of Medicine is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research, education, and patient care. With a strong emphasis on translating scientific discoveries into practical applications, the institution conducts a diverse array of clinical trials aimed at improving treatment outcomes and enhancing the understanding of various medical conditions. Its collaborative environment fosters partnerships between researchers, clinicians, and community stakeholders, ensuring that the trials not only contribute to scientific knowledge but also address the pressing health needs of diverse populations.

Locations

Saint Louis, Missouri, United States

Patients applied

0 patients applied

Trial Officials

Alex Ramsey, Ph.D.

Principal Investigator

Washington University School of Medicine

Li-Shiun Chen, M.D., MPH, ScD

Principal Investigator

Washington University School of Medicine

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials